UBS Initiates Aetna with a “Buy” Rating (AET)
UBS reported on Friday that it has initiated coverage of healthcare benefits company, Aetna Inc. (AET).
The firm has begun coverage of AET with a “Buy” rating and $63 price target. This price target suggests a 13% increase from the stock’s current price of $54.60.
Analysts have given the company a “Buy” rating based on the Coventry Healthcare acquisition which will help the company reach its 10% EPS compounded annual growth rate target.
Aetna shares were mostly flat during premarket trading Friday. The stock has increased 9% in the past year.
The Bottom Line
Shares of Aetna Inc. (AET) have a 1.47% yield, based on Thursday’s closing price of $54.60.
Aetna Inc. (AET) is not recommended at this time, holding a Dividend.com DARS™ Rating of 3.4 out of 5 stars.
Get FREE Dividend Tips, Updates & MoreWe respect your privacy
- Powerful dividend insights sent every weekday morning
- Gain instant access to actionable investing tips
- Strategically grow your portfolio’s profitability